Acorda Therapeutics reported $33.01M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US USD 130.71M 3.85M
Acorda Therapeutics ACOR:US USD 33.01M 1.96M
Agios Pharmaceuticals AGIO:US USD 3.52M 2.07M
ALKERMES ALKS:US USD 252.36M 23.86M
Amgen AMGN:US USD 6.65B 58M
Anika Therapeutics ANIK:US USD 40.26M 607K
Arrowhead Research ARWR:US USD 31.58M 837K
Biogen BIIB:US USD 2.51B 80.6M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Cara Therapeutics CARA:US USD 10.81M 12.19M
Clovis Oncology CLVS:US USD 30.66M 1.48M
Cytokinetics CYTK:US USD 2.51M 86.45M
Enanta Pharmaceuticals ENTA:US USD 20.32M 838K
Gilead Sciences GILD:US USD 7.04B 782M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Halozyme Therapeutics HALO:US USD 208.98M 56.61M
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Insmed INSM:US USD 67.73M 2.51M
Ligand Pharmaceuticals LGND:US USD 62.51M 5.09M
Mannkind MNKD:US USD 32.82M 13.93M
Merck MRK:GR EUR 5.81B 238M
Moderna Inc MRNA:US USD 3.36B 1.38B
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Novartis NOVN:VX USD 12.84B 243M
Pfizer PFE:US USD 22.64B 5.1B
Teva Pharmaceutical TEVA:IT USD 3.6B 191M
Ultragenyx Pharmaceutical RARE:US USD 90.7M 1.36M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M